RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Valeant Pharmaceuticals International

A collection of news and information related to Valeant Pharmaceuticals International published by this site and its partners.

Top Valeant Pharmaceuticals International Articles

Displaying items 1-12
  • Deerfield drugmaker defies Democrats' anti-inversion effort

    Deerfield drugmaker defies Democrats' anti-inversion effort
    Horizon Pharma Inc., a Deerfield-based specialty drugmaker, shifted its corporate address to Ireland Friday, defying a threat by Democratic lawmakers to unwind such maneuvers retroactively. Now known as Horizon Pharma, it's the first company to complete...
  • Allergan reaches truce with suitors on special shareholder meeting

    (Reuters) - Allergan Inc has agreed not to throw up any roadblocks to a special shareholder meeting on Dec. 18, giving Pershing Square Capital Management a chance to attempt its threatened replacement of Allergan board members. The battling parties...
  • Valeant, Ackman get October 6 trial over Allergan special meeting

    WILMINGTON Del. (Reuters) - Valeant Pharmaceuticals International Inc and activist investor William Ackman got their request for an expedited trial on Wednesday over the timing of a special meeting of Allergan Inc shareholders, a key to their $50...
  • Valeant, Ackman to submit Allergan special meeting request-CNBC

    (Reuters) - Valeant Pharmaceuticals International Inc and Pershing Square Capital Management will submit a request on Friday to Allergan Inc for a special shareholders meeting, sources told CNBC television. Allergan's corporate bylaws require Valeant and...
  • U.S. court denies Allergan bid to speed insider trading suit

    (Reuters) - A federal judge in California on Thursday denied a request by Allergan Inc to expedite its civil suit claiming that Valeant Pharmaceuticals International Inc and Pershing Square Capital Management engaged in insider trading ahead of their...
  • Allergan seeks deal with Salix to fend off Valeant: WSJ

    (Reuters) - Botox maker Allergan Inc has approached Salix Pharmaceuticals Ltd and at least one other company about a potential takeover in a bid to avert the $53 billion hostile takeover from Valeant Pharmaceuticals International Inc, the Wall Street...
  • Allergan fights back: Botox maker reportedly pursuing Salix; stocks up

    Botox maker Allergan Inc. of Irvine is reportedly interested in acquiring a North Carolina drugmaker, part of its effort to fight off a takeover attempt by a Canadian rival. The stock market responded, driving Allergan shares up 4%. Allergan's Tuesday...
  • SEC is investigating bid by Valeant and Bill Ackman for Allergan

    SEC is investigating bid by Valeant and Bill Ackman for Allergan
    The Securities and Exchange Commission is looking into the way a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine. Word of the investigation came less than a week after Allergan sued...
  • Pershing Square sues U.S. over Fannie Mae, Freddie Mac

    Pershing Square sues U.S. over Fannie Mae, Freddie Mac
    Pershing Square Capital Management LP, the hedge fund firm run by William Ackman, has sued the U.S. government, claiming that its stripping of Fannie Mae's and Freddie Mac's profit illegally short changes investors in the mortgage companies' common stock....
  • SEC reviewing attempted takeover of Botox maker Allergan

    The Securities and Exchange Commission is looking into the way that a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine, Calif. Ackman's hedge fund, Pershing Square Capital Management,...
  • Pershing Square Holdings fund up 27.2 percent year to date through July

    BOSTON (Reuters) - Billionaire investor William Ackman's Pershing Square Holdings has risen 27.2 percent this year, according to an investor in the fund, after extending its gains modestly last month when many hedge fund managers suffered losses. The...
  • Allergan to slash workforce by 1,500

    Allergan to slash workforce by 1,500
    Botox maker Allergan Inc. said Monday that it will cut 1,500 employees, most of them in Southern California, in a cost-cutting effort the Irvine company hopes will help it fight off a hostile takeover bid by a Canadian rival. Stung by criticism that it'...